Hanoi Medical University is the oldest university of Vietnam and is located in Hanoi. HMU was founded in 1902 by French during the French colonisation under the name Indochina Medical College.

During the past decade, Hanoi medical university conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hanoi medical university" #1 sponsor was "Hanoi Medical University" with 7 trials, followed by "Actelion" with 5 trials sponsored, "Karolinska Institutet" with 2 trials sponsored, "Emory University" with 1 trials sponsored and "Gene Solutions" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hanoi medical university" #1 collaborator was "Hanoi Medical University" with 6 trials as a collaborator, "Bach Mai Hospital" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Can Tho Oncology Hospital" with 1 trials as a collaborator and "Center for Creative Initiatives in Health and Population" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hanoi medical university" are "Pulmonary Arterial Hypertension" (4 trials), "Human Immunodeficiency Virus (HIV)" (2 trials), "Acute Appendicitis" (1 trials), "COVID-19 Disease" (1 trials) and "COVID-19 Vaccine" (1 trials). Many other conditions were trialed in "Hanoi medical university" in a lesser frequency.

Most popular intervention types in "Hanoi medical university" are "Drug" (7 trials), "Other" (6 trials), "Behavioral" (4 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Enhanced Treatment Support (ETS)" (2 trials), "Macitentan 10 mg" (2 trials), "A standard image training set" (1 trials) and "AFP-L3 and PIVKA-II in HCC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hanoi medical university" are 19 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hanoi medical university". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hanoi medical university, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hanoi medical university, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".